Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion type Assertion NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_head.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion description "[Characterization of amplified regions of the genome in breast cancer has led to the identification of important oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion evidence source_evidence_literature NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion SIO_000772 14729606 NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion wasDerivedFrom befree-2016 NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.
- NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_assertion wasGeneratedBy ECO_0000203 NP428417.RABXgF_JIy0KSuYsFZeftD0N1fWC4esIiH2_z3OidF0mY130_provenance.